Nanotherapy may reduce fibrosis and improve cancer immunotherapy response

Science reports that targeting senescence decreases fibrosis and boosts cancer cells’ response to immunotherapy. Its research summary identifies senescent-like cells as drivers of fibrosis and describes how fibrotic changes create immune-suppressing environments that impair organ function and limit immunotherapy response in cancer.